459 related articles for article (PubMed ID: 19604496)
1. D(1)/D(2) receptor-targeting L-stepholidine, an active ingredient of the Chinese herb Stephonia, induces non-rapid eye movement sleep in mice.
Qiu MH; Qu WM; Xu XH; Yan MM; Urade Y; Huang ZL
Pharmacol Biochem Behav; 2009 Nov; 94(1):16-23. PubMed ID: 19604496
[TBL] [Abstract][Full Text] [Related]
2. GABA transporter-1 inhibitor NO-711 alters the EEG power spectra and enhances non-rapid eye movement sleep during the active phase in mice.
Xu XH; Qiu MH; Dong H; Qu WM; Urade Y; Huang ZL
Eur Neuropsychopharmacol; 2014 Apr; 24(4):585-94. PubMed ID: 24080505
[TBL] [Abstract][Full Text] [Related]
3. Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, induces sleep via the benzodiazepine site of GABA(A) receptor in mice.
Chen CR; Zhou XZ; Luo YJ; Huang ZL; Urade Y; Qu WM
Neuropharmacology; 2012 Nov; 63(6):1191-9. PubMed ID: 22771461
[TBL] [Abstract][Full Text] [Related]
4. State-dependent pattern of Fos protein expression in regionally-specific sites within the preoptic area of the cat.
Torterolo P; Benedetto L; Lagos P; Sampogna S; Chase MH
Brain Res; 2009 Apr; 1267():44-56. PubMed ID: 19269274
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat.
Ongini E; Bonizzoni E; Ferri N; Milani S; Trampus M
J Pharmacol Exp Ther; 1993 Aug; 266(2):726-31. PubMed ID: 8102647
[TBL] [Abstract][Full Text] [Related]
6. c-Fos expression in preoptic nuclei as a marker of sleep rebound in the rat.
Dentico D; Amici R; Baracchi F; Cerri M; Del Sindaco E; Luppi M; Martelli D; Perez E; Zamboni G
Eur J Neurosci; 2009 Aug; 30(4):651-61. PubMed ID: 19686475
[TBL] [Abstract][Full Text] [Related]
7. Honokiol promotes non-rapid eye movement sleep via the benzodiazepine site of the GABA(A) receptor in mice.
Qu WM; Yue XF; Sun Y; Fan K; Chen CR; Hou YP; Urade Y; Huang ZL
Br J Pharmacol; 2012 Oct; 167(3):587-98. PubMed ID: 22537192
[TBL] [Abstract][Full Text] [Related]
8. L-stepholidine, a natural dopamine receptor D1 agonist and D2 antagonist, inhibits heroin-induced reinstatement.
Ma B; Yue K; Chen L; Tian X; Ru Q; Gan Y; Wang D; Jin G; Li C
Neurosci Lett; 2014 Jan; 559():67-71. PubMed ID: 24269875
[TBL] [Abstract][Full Text] [Related]
9. Compensatory sleep responses to wakefulness induced by the dopamine autoreceptor antagonist (-)DS121.
Olive MF; Seidel WF; Edgar DM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1073-83. PubMed ID: 9618410
[TBL] [Abstract][Full Text] [Related]
10. Effect of (-)-stepholidine on serum prolactin level of female rats.
Zou LL; Chen Y; Song YY; Jin GZ
Zhongguo Yao Li Xue Bao; 1996 Jul; 17(4):311-4. PubMed ID: 9812710
[TBL] [Abstract][Full Text] [Related]
11. Studies on wakefulness-promoting effect of memantine in rats.
Ishida T; Obara Y; Kamei C
Behav Brain Res; 2010 Jan; 206(2):274-8. PubMed ID: 19781580
[TBL] [Abstract][Full Text] [Related]
12. Effects of selective dopamine D4 receptor antagonist, L-741,741, on sleep and wakefulness in the rat.
Cavas M; Navarro JF
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):668-78. PubMed ID: 16457926
[TBL] [Abstract][Full Text] [Related]
13. Essential role of dopamine D2 receptor in the maintenance of wakefulness, but not in homeostatic regulation of sleep, in mice.
Qu WM; Xu XH; Yan MM; Wang YQ; Urade Y; Huang ZL
J Neurosci; 2010 Mar; 30(12):4382-9. PubMed ID: 20335474
[TBL] [Abstract][Full Text] [Related]
14. Blockage of dopaminergic D(2) receptors produces decrease of REM but not of slow wave sleep in rats after REM sleep deprivation.
Lima MM; Andersen ML; Reksidler AB; Silva A; Zager A; Zanata SM; Vital MA; Tufik S
Behav Brain Res; 2008 Apr; 188(2):406-11. PubMed ID: 18201777
[TBL] [Abstract][Full Text] [Related]
15. Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice.
Huang ZL; Mochizuki T; Qu WM; Hong ZY; Watanabe T; Urade Y; Hayaishi O
Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4687-92. PubMed ID: 16537376
[TBL] [Abstract][Full Text] [Related]
16. Wake-promoting actions of dopamine D1 and D2 receptor stimulation.
Isaac SO; Berridge CW
J Pharmacol Exp Ther; 2003 Oct; 307(1):386-94. PubMed ID: 12944496
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic control of sleep.
Szymusiak R; Gvilia I; McGinty D
Sleep Med; 2007 Jun; 8(4):291-301. PubMed ID: 17468047
[TBL] [Abstract][Full Text] [Related]
18. Behavioral and sleep/wake characteristics of mice lacking norepinephrine and hypocretin.
Hunsley MS; Curtis WR; Palmiter RD
Genes Brain Behav; 2006 Aug; 5(6):451-7. PubMed ID: 16923149
[TBL] [Abstract][Full Text] [Related]
19. Focused motor stereotypies do not require enhanced activation of neurons in striosomes.
Glickstein SB; Schmauss C
J Comp Neurol; 2004 Feb; 469(2):227-38. PubMed ID: 14694536
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruption.
Paterson LM; Wilson SJ; Nutt DJ; Hutson PH; Ivarsson M
J Psychopharmacol; 2009 Jul; 23(5):475-86. PubMed ID: 19395429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
